ArticleJournal of asthma and allergy2021

Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study.

Soichiro Hozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.